Gilead Sciences, Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GILD.MX | LLY | NVS | BMY | MRK | BIIB | |
|---|---|---|---|---|---|---|
| Market cap | 3.56T | 1.11T | 285.63B | 120.48B | 355.30B | 34.68B |
| P/E (TTM) | — | 41.9 | 22.7 | 13.0 | 114.3 | 41.7 |
| Forward P/E | — | 26.5 | 15.3 | 8.9 | 15.5 | 14.2 |
| Price/book | 16.3 | 32.9 | 6.9 | 5.4 | 8.5 | 1.8 |
| Dividend yield | 2.05% | 0.55% | 3.15% | 4.22% | 2.33% | — |
| 1-year change | +27.10% | +55.39% | +14.29% | +37.07% | +69.08% | +58.66% |
| Today | −1.71% | −0.66% | −0.23% | −1.29% | −1.33% | +0.89% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All GILD.MX news ›Gilead Sciences Inc. Stock , GILD
Gilead Sciences Stock Price | GILD Stock Quote, News, and History markets.businessinsider.com Gilead Sciences Inc. Stock , GILD Gilead Sciences Stock Snapshot Gilead Sciences News More News Gilead Sciences (GILD) Rises Higher Than Market:…
Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow?
The Motley Fool Gilead Sciences (GILD -0.75%), a biotech leader, has outperformed broader equities this year. The company's financial results have been fairly strong, contributing to its year-to-date performance. However, another factor…
Analysts Conflicted on These Healthcare Names: Gilead Sciences (GILD) and Edwards Lifesciences (EW)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gilead Sciences (GILD) and Edwards Lifesciences (EW). Leerink Partners analyst Daina Graybosch maintained a Hold rating on Gilead Sciences today and set a…
Comparing Gilead Sciences (NASDAQ:GILD) and Akebia Therapeutics (NASDAQ:AKBA)
Posted by Defense World Staff on Oct 19th, 2026 Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) and Gilead Sciences (NASDAQ:GILD – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast…
Insider Selling: Gilead Sciences (NASDAQ:GILD) CFO Sells $468,660.00 in Stock
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) CFO Andrew Dickinson sold 3,000 shares of the business’s stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $156.22, for a total transaction…
Gilead Sciences, Inc. $GILD Stake Cut by TD Waterhouse Canada Inc.
Check Out Our Latest Report on Gilead Sciences The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 29th. Investors of record on Tuesday, September 15th were paid a dividend of $0.82 per share. This…
Analysts Have Conflicting Sentiments on These Healthcare Companies: Gilead Sciences (GILD) and HealthStream (HSTM)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gilead Sciences (GILD) and HealthStream (HSTM). Wells Fargo analyst Mohit Bansal maintained a Buy rating on Gilead Sciences yesterday and set a price target…
Gilead Sciences to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026
BioSpace Gilead Sciences to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026 FOSTER CITY, Calif.--(BUSINESS WIRE)--#Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2026…
Goldman Sachs Adjusts Price Target on Gilead Sciences to $142 From $135
Gilead Sciences has an average rating of overweight and mean price target of $161, according to analysts polled by FactSet. ... Published on 10/15/2026 at 06:41 am EDT Gilead to Buy Cancer Biotech Tubulis in $5B Deal April 08, 2026 at…
BofA Securities Adjusts Gilead Sciences Price Target to $168 From $162, Maintains Buy Rating
Gilead Sciences has an average rating of overweight and mean price target of $160.52, according to analysts polled by FactSet. ... BofA Securities Adjusts Gilead Sciences Price Target to $168 From $162, Maintains Buy Rating Published on…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com17
-
marketbeat.com10
-
stocktitan.net8
-
gurufocus.com6
-
tradingview.com5
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 94 articles, not a forecast.